These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1595711)

  • 1. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion.
    Gonthier DM; Hartman G; Holley JL
    Am J Kidney Dis; 1992 Jun; 19(6):600-3. PubMed ID: 1595711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cutaneous Monomorphic Post-transplant Lymphoproliferative Disorder Mimicking Squamous Cell Carcinoma In Situ.
    Craddock AP; Gru AA; Mannschreck D; Wilson BB; Raghavan SS
    Am J Dermatopathol; 2021 Dec; 43(12):e234-e236. PubMed ID: 33899771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.
    Snavely NR; Sonabend M; Rosen T
    Dermatol Online J; 2007 Oct; 13(4):7. PubMed ID: 18319004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation.
    Chen KY; Lin CY; Kuo TT; Shih LY; Chang CH; Chen WT; Yang CY
    Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
    Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
    Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous non-Hodgkin lymphoma of the leg occurring 11 years after renal transplantation].
    Kudo K; Sonoda M; Sugimoto K; Koike M
    Rinsho Ketsueki; 2009 Feb; 50(2):107-9. PubMed ID: 19265304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
    Birkeland SA; Bendtzen K; Møller B; Hamilton-Dutoit S; Andersen HK
    Transplantation; 1999 Mar; 67(6):876-81. PubMed ID: 10199737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
    Lager DJ; Slagel DD; Burgart LJ
    Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.
    Mañez R; Breinig MC; Linden P; Wilson J; Torre-Cisneros J; Kusne S; Dummer S; Ho M
    J Infect Dis; 1997 Dec; 176(6):1462-7. PubMed ID: 9395355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
    Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
    J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
    Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
    Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA; Meier JD; Stallworth CR; White DR
    Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Solid Mass in the Chest Wall.
    Alagoz S; Yalin SF; Gulcicek S; Ozgur N; Altiparmak MR; Seyahi N
    Prog Transplant; 2016 Dec; 26(4):386-388. PubMed ID: 27555070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
    Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA
    Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S; Lachat V; Moulin B
    Transpl Int; 2000; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.